| Literature DB >> 29785400 |
Liliany Souza de Brito Amaral1, Cláudia Silva Souza1, Rildo Aparecido Volpini2, Maria Heloisa Massola Shimizu2, Ana Carolina de Bragança2, Daniele Canale2, Antonio Carlos Seguro2, Terezila Machado Coimbra3, Amélia Cristina Mendes de Magalhães1, Telma de Jesus Soares1.
Abstract
The aim of this study is to evaluate the effects of regular moderate exercise training initiated previously or after induction of diabetes mellitus on renal oxidative stress and inflammation in STZ-induced diabetic female rats. For this purpose, Wistar rats were divided into five groups: sedentary control (SC), trained control (TC), sedentary diabetic (SD), trained diabetic (TD), and previously trained diabetic (PTD). Only the PTD group was submitted to treadmill running for 4 weeks previously to DM induction with streptozotocin (40 mg/kg, i.v). After confirming diabetes, the PTD, TD, and TC groups were submitted to eight weeks of exercise training. At the end of the training protocol, we evaluated the following: glycosuria, body weight gain, plasma, renal and urinary levels of nitric oxide and thiobarbituric acid reactive substances, renal glutathione, and immunolocalization of lymphocytes, macrophages, and nuclear factor-kappa B (NF-κB/p65) in the renal cortex. The results showed that exercise training reduced glycosuria, renal TBARS levels, and the number of immune cells in the renal tissue of the TD and PTD groups. Of note, only previous exercise increased weight gain and urinary/renal NO levels and reduced NF-κB (p65) immunostaining in the renal cortex of the PTD group. In conclusion, our study shows that exercise training, especially when initiated previously to diabetes induction, promotes protective effects in diabetic kidney by reduction of renal oxidative stress and inflammation markers in female Wistar rats.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29785400 PMCID: PMC5896236 DOI: 10.1155/2018/6170352
Source DB: PubMed Journal: J Diabetes Res Impact factor: 4.011
Body weight gain and glycosuria of SC, TC, SD, TD, and PTD rats.
| SC | TC | SD | TD | PTD | |
|---|---|---|---|---|---|
| ΔBW (%) | 84.15 ± 12.7 | 64.40 ± 4.9 | −4.507 ± 3.3∗∗∗ | 2.816 ± 8.9∗∗∗ | 28.67 ± 12.8∗# |
| Glycosuria (mg/24 h) |
|
| 2481 ± 328.5 | 1301 ± 119.5## | 1192 ± 99.61## |
Data are expressed as mean ± standard error. ΔBW: body weight gain. ∗∗∗p < 0.001 and ∗p < 0.05 versus SC and TC; ##p < 0.01 and #p < 0.05 versus SD. The ΔBW was calculated by the equation [(final weight − initial weight)/initial weight] × 100.
TBARS and NO levels in serum, urine, and kidney and GSH levels in the kidney of SC, TC, SD, TD, and PTD rats.
| SC | TC | SD | TD | PTD | |
|---|---|---|---|---|---|
|
| |||||
| TBARS (nm/mg) | 0.38 ± 0.08 | 0.39 ± 0.08 | 1.96 ± 0.45∗∗ | 0.86 ± 0.15# | 1.26 ± 0.09# |
| NO ( | 15.11 ± 2.85 | 22.13 ± 2.31 | 9.09 ± 1.72∗ | 6.34 ± 1.11∗ | 19.09 ± 2.88#†† |
| GSH ( | 0.35 ± 0.04 | 0.31 ± 0.04 | 0.40 ± 0.08 | 0.28 ± 0.04 | 0.25 ± 0.05 |
|
| |||||
| TBARS (nm/mL) | 1.29 ± 0.2 | 1.38 ± 0.12 | 1.15 ± 0.11 | 1.33 ± 0.28 | 1.75 ± 0.18 |
| NO ( | 71.92 ± 25.52 | 137.5 ± 26.73 | 86.60 ± 15.50 | 111.5 ± 17.09 | 102.3 ± 21.23 |
|
| |||||
| TBARS (nm/24 h) | 186.9 ± 21.09 | 118.3 ± 21.15 | 217.5 ± 70.02 | 231.4 ± 58.36 | 252.3 ± 42.99 |
| NO ( | 12.09 ± 2.32 | 14.73 ± 1.44 | 5.18 ± 1.97∗ | 8.56 ± 2.72 | 15.52 ± 3.49# |
Data are expressed as mean ± standard error. TBARSS, TBARSU, and TBARSR; thiobarbituric acid reactive substance serum (nm/mL), urinary (nm/24 h), and renal tissue (nm/mg), respectively; GSHR: renal glutathione (μmol/mg); NOS, NOU, and NOR; nitric oxide serum (μmol/mL), urinary (μmol/24 h), and renal tissue (μmol/mg), respectively. ∗∗p < 0.01 and ∗p < 0.05 versus SC and TC; #p < 0.05 versus SD; ††p < 0.01 versus TD.
Figure 1Correlation between TBARS and NO renal levels of SC, TC, SD, TD, and PTD rats. n = 5 for all groups. Pearson's correlation, r = −0.54, p < 0.01.
Renal immunostaining for ED-1, CD43, and NF-κB (p65) of SC, TC, SD, TD, and PTD rats.
| SC | TC | SD | TD | PTD | |
|---|---|---|---|---|---|
| ED-1 | 3.9 ± 0.2 | 3.6 ± 0.2 | 6.9 ± 0.9∗ | 6.3 ± 0.6 | 4.8 ± 1.0 |
| CD43 |
|
| 7.0 ± 0.5 | 2.8 ± 0.8## | 1.7 ± 0.7## |
| NF- | 0.5 ± 0.3 | 0.9 ± 0.3 | 4.7 ± 0.9∗ | 6.1 ± 1.4∗∗ | 1.3 ± 0.6##†† |
Data are expressed as mean ± standard error. ED-1: macrophage marker; CD43: lymphocyte marker; and NF-κB: nuclear factor kappa B. ∗∗p < 0.01 and ∗p < 0.05 versus SC and TC; ##p < 0.01 versus SD; ††p < 0.01 versus TD.
Figure 2Immunolocalization of CD43 in the renal cortex of SC (a), SD (b), TD (c), and PTD (d) rats. Note the less intensity of CD43 immunostainings in PTD. Original magnification ×200.
Figure 3Immunolocalization of ED-1 in the renal cortex of SC (a), SD (b), TD (c), and PTD (d) rats. Note the less intensity of ED-1 immunostainings in PTD. Original magnification ×200.
Figure 4Immunolocalization of NF-κB (p65) in the renal cortex of SC (a), SD (b), TD (c), and PTD (d) rats. Note the nuclear immunostaining of NF-κB in (e), suggesting the migration of this factor to the nucleus. Note also lesser intensity of NF-κB immunostaining in PTD. Original magnification ×200.